Thomas RappHealth Economist, National Institutes of Health and Medical Research (INSERM U558)Toulouse - FranciaDesign of cost-effectiveness analyses and budget impact models for both the pharmaceutical and insurance industries. Pharmacoeconomics, pharmaceutical/health outcomes research, pharmaceutical pricing, and economic analysis of the pharmaceutical industry. Study and Design of ESOP Adoption, Employee Stock Ownership, Defined Contribution Plan, Defined ... |
Since 2009: Health Economist |
In charge of health economics and pharmacoeconomics studies at INSERM U558 http://thomas.rapp.free.fr/ |
Since 2008: Member of the scientific committee |
Employee Stock Ownership Plans Employee Stock Participation Plans Pension Plans www.fondact.org |
2007 - 2009 : Postdoctoral Fellow |
Health Services Research Pharmacoeconomics Budget Impact Analysis Cost-Effectiveness Studies Member of the International Society For Pharmacoeconomics and Outcomes Research (ISPOR) |
2003 - 2007 : Graduate Student - Assistant Teacher Microeconomics |
Member of the French Finance Association (AFFI) Member (co-founder) of the Employee Stock Ownership Network (EORN) Dissertation: The Effect of Employee Stock Ownership Plans on Employees' Savings Behaviors |
2002 - 2003 : Research Assistant |
CEPII is France's leading institute for research on International Economics Economic Forecasting www.cepii.fr |
2001 : Editorial Assistant |
Internship -The Journal of Nutrition Health and Aging -La Lettre Mensuelle de l'Année Gérontologique www.serdi-fr.com |
Former student of |
Inglés
|
Francés
|
 | | |
| ||
| | |
